Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $25.75 USD
Change Today -0.56 / -2.13%
Volume 40.5K
FWP On Other Exchanges
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

forward pharma a/s-adr (FWP) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/23/15 - $43.34
52 Week Low
10/15/14 - $15.75
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for FORWARD PHARMA A/S-ADR (FWP)

forward pharma a/s-adr (FWP) Related Bloomberg News

View More Bloomberg News

forward pharma a/s-adr (FWP) Related Businessweek News

No Related Businessweek News Found

forward pharma a/s-adr (FWP) Details

Forward Pharma A/S operates as a biopharmaceutical company. The company engages in developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

10 Employees
Last Reported Date: 03/25/15
Founded in 2005

forward pharma a/s-adr (FWP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

forward pharma a/s-adr (FWP) Key Developments

Forward Pharma A/S Announces Executive Appointments

On July 22, 2015, Forward Pharma A/S announced that at its the extraordinary general meeting of its shareholders held on July 20, 2015, approved the election of Jakob Mosegaard Larsen and Grant Hellier Lawrence as the additional members of the board of directors.

Forward Pharma A/S, Special/Extraordinary Shareholders Meeting, Jul 20, 2015

Forward Pharma A/S, Special/Extraordinary Shareholders Meeting, Jul 20, 2015., at 14:00 Central European Standard Time. Location: stergade 24A, 1st floor. Agenda: To consider election of two new members to the board of directors; and to approve authorization of the chairman of the general meeting.

Forward Pharma Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Forward Pharma announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. Net income for the period attributable to equity holders of the parent was USD 5.3 million, or USD 0.11 per share compared to a net loss of USD 5.3 million, or USD 0.18 per share in first quarter of 2014. On a non-GAAP basis, after removing the effect of non-cash income and expense items, first quarter net loss for 2015 would have been approximately USD 6.9 million, or USD 0.15 per share. The comparable amounts for 2014 would have been a net loss of USD 4.2 million or USD 0.14 per share. Net income for the first quarter of 2015 benefiting from non-cash foreign currency gains of USD 14.3 million, which more than offset operating expenses of USD 8.4 million. Net income before taxes was USD 6,026,000 against loss of USD 5,358,000 a year ago. Net cash flows used in operating activities was USD 5,081,000 against USD 2,306,000 a year ago. Purchase of equipment was USD 126,000.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FWP:US $25.75 USD -0.56

FWP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FWP.
View Industry Companies

Industry Analysis


Industry Average

Valuation FWP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 6.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FORWARD PHARMA A/S-ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at